Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Mirxes Holding Company Limited ( (HK:2629) ) is now available.
Mirxes Holding Company Limited has signed a memorandum of understanding with Apollo Health and Lifestyle Limited, a subsidiary of India’s Apollo Hospitals Enterprise Limited, to explore a strategic collaboration in co-developing and commercializing advanced cancer early detection solutions in India and neighboring countries. Subject to agreed objectives and board approvals, the partners expect to establish a joint venture in India valued at no less than US$50 million, underpinned by intellectual property, clinical pipelines, R&D, testing infrastructure and commercial channels contributed by both sides.
The proposed collaboration combines Mirxes’ proprietary cancer screening technologies and products with Apollo’s extensive clinical expertise and hospital network to drive large-scale commercialization and market adoption of early disease screening across the region. The joint venture would license Mirxes’ intellectual property for the Indian market, expand into broader preventive and precision diagnostics using AI and data analytics, leverage Apollo’s screening facilities, pharmacies and digital platforms for distribution, and pursue alliances with other biopsy and genomic cancer firms to strengthen its global presence through the MOU term ending November 18, 2026.
More about Mirxes Holding Company Limited
Mirxes Holding Company Limited is a molecular diagnostics company that develops and commercializes advanced cancer early detection tests using miRNA and multi-omics technologies. Its core products include GASTROClear and LUNGClear, with a clinical pipeline targeting colorectal, liver and breast cancers, as well as multi-cancer tests, primarily focused on early disease screening in Asia.
Average Trading Volume: 1,459,414
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$5.13B
Find detailed analytics on 2629 stock on TipRanks’ Stock Analysis page.